Compare TMCWW & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TMCWW | SNN |
|---|---|---|
| Founded | 2011 | 1856 |
| Country | Canada | United Kingdom |
| Employees | 47 | N/A |
| Industry | Metal Mining | Industrial Specialties |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 13.9B |
| IPO Year | N/A | 1999 |
| Metric | TMCWW | SNN |
|---|---|---|
| Price | $1.45 | $33.96 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $32.83 |
| AVG Volume (30 Days) | 131.8K | ★ 599.2K |
| Earning Date | 03-24-2025 | 02-24-2026 |
| Dividend Yield | N/A | ★ 2.17% |
| EPS Growth | N/A | ★ 59.91 |
| EPS | N/A | ★ 0.56 |
| Revenue | N/A | ★ $5,944,000,000.00 |
| Revenue This Year | N/A | $7.71 |
| Revenue Next Year | N/A | $5.23 |
| P/E Ratio | ★ N/A | $60.38 |
| Revenue Growth | N/A | ★ 5.35 |
| 52 Week Low | $0.04 | $23.69 |
| 52 Week High | $0.32 | $38.79 |
| Indicator | TMCWW | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 48.55 | 59.66 |
| Support Level | $1.40 | $32.42 |
| Resistance Level | $1.68 | $34.20 |
| Average True Range (ATR) | 0.21 | 0.40 |
| MACD | -0.03 | 0.17 |
| Stochastic Oscillator | 22.39 | 86.52 |
TMC The Metals Co Inc is a deep-sea minerals exploration company focused on the collection, processing, and refining of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone (CCZ). Polymetallic nodules are discrete rocks that sit unattached to the seafloor, occur in notable quantities in the CCZ, and have high concentrations of nickel, copper, cobalt, and manganese in a single rock. The company believes these four metals contained in the polymetallic nodules are critical for energy infrastructure and industrial manufacturing. The Company's business consists of only one operating segment, namely exploration of seafloor polymetallic nodules, which includes the development of a metallurgical process to treat such seafloor polymetallic nodules.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.